Loading...
Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Ciprofloxacin, the first fluoroquinolone to be used to treat lower respiratory tract infections (LRTI), demonstrates poor potency against Streptococcus pneumoniae, and its use has been associated with the emergence of resistance. During the last decade, fluoroquinolones with enhanced in vitro activi...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3147653/ https://ncbi.nlm.nih.gov/pubmed/21628545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00237-11 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|